File:CCL3L1-CCR5 Genotype Improves the Assessment of AIDS Risk in HIV-1-Infected Individuals -Figure 3.png
CCL3L1-CCR5_Genotype_Improves_the_Assessment_of_AIDS_Risk_in_HIV-1-Infected_Individuals_-Figure_3.png (566 × 600 pixels, file size: 155 KB, MIME type: image/png)
Captions
DescriptionCCL3L1-CCR5 Genotype Improves the Assessment of AIDS Risk in HIV-1-Infected Individuals -Figure 3.png |
CCL3L1-CCR5 GRGs influence median time-from-seroconversion to CD4 cell count thresholds that might be used to guide initiation of HAART, and time from a high to a low CD4 cell count. In Panel A, KM plots show the time-from-seroconversion to arrival at <450 (left), <350 (center) or <200 (right) CD-cells/mm3. In Panel B, the KM plots are for progression from <450 to <200 CD4-cells/mm3 in all seroconverters (left) or seroconverters recruited and followed during the years 1990 to 1999, a time-period in which antiretroviral therapy was available (right). The color codes for the KM plots in panel B are: blue, low GRG; brown, moderate and high GRGs combined into a single category; and black, all subjects. Overall P values are at the top of each plot. Color-coded numbers at the upper right of the KM plots represent the median time-to-event, that is, from seroconversion to the indicated CD4 cell count. In panel A, P values for differences in median time-to-event relative to those with a low GRG were: *, 0.1131; †, 0.0089; ‡, 0.0030; §, 0.0005; ¶, 0.0001; and ∥, 9.6×10−7. RH, relative hazard; CI, confidence interval. P values in Panel B are adjusted for the steady-state viral load, baseline CD4 and best DTH response recorded during disease course, and subjects with a moderate or high GRG were combined into a single category. Uploaded for use in s: CCL3L1-CCR5 Genotype Improves the Assessment of AIDS Risk in HIV-1-Infected Individuals |
Date | Sept 08 |
Source | http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0003165 |
Author | Hemant Kulkarni, Brian K. Agan, Vincent C. Marconi, Robert J. O'Connell, Jose F. Camargo, Weijing He, Judith Delmar, Kenneth R. Phelps, George Crawford, Robert A. Clark, Matthew J. Dolan, Sunil K. Ahuja |
Permission (Reusing this file) |
This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. |
This file has been released explicitly into the public domain by its author, using the Creative Commons Public Domain Dedication formerly here
This file may be used for any purpose including unrestricted redistribution, commercial use, and modification. Note: Creative Commons has retired this legal tool and does not recommend that it be applied to works. It is recommended you use {{Cc-zero}} instead. Creative Commons Public Domain DedicationPublic Domainhttps://web.archive.org/web/20230926203737/https://creativecommons.org/licenses/publicdomain/false
This legal tool may not be effective or applicable in non-US jurisdictions. |
File history
Click on a date/time to view the file as it appeared at that time.
Date/Time | Thumbnail | Dimensions | User | Comment | |
---|---|---|---|---|---|
current | 11:01, 14 September 2008 | 566 × 600 (155 KB) | Anonymous101 (talk | contribs) | {{Information |Description= CCL3L1-CCR5 GRGs influence median time-from-seroconversion to CD4 cell count thresholds that might be used to guide initiation of HAART, and time from a high to a low CD4 cell count. In Panel A, KM plots show the time-from-ser |
You cannot overwrite this file.
File usage on Commons
There are no pages that use this file.
File usage on other wikis
The following other wikis use this file:
- Usage on en.wikisource.org